Skip to content

Celcuity CELC Deferred Tax Assets

Deferred Tax Assets at other companies

Eli Lilly logo
Eli LillyLLY
$11.35B+32.4%
Gilead Sciences logo
Gilead SciencesGILD
$179M-74.8%
Tenet Healthcare logo
Tenet HealthcareTHC
$199M-11.9%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$3.93M+114%
TG Therapeutics logo
TG TherapeuticsTGTX
$344.14M
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$381.4M-23.6%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.4B+1,370%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost.

The official record: Celcuity’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's deferred tax assets?
Celcuity (CELC) reported deferred tax assets of $6.06M in Q4 2025.
How has Celcuity's deferred tax assets changed year-over-year?
Celcuity's deferred tax assets increased by 111.7% year-over-year, from $2.86M to $6.06M.
What is the long-term trend for Celcuity's deferred tax assets?
Over 5 years (2020 to 2025), Celcuity's deferred tax assets has grown at a 62.9% compound annual growth rate (CAGR), from $528K to $6.06M.
What does deferred tax assets mean?
Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.